Kronig, H; Hofer, K; Conrad, H et al.
Allorestricted T lymphocytes with a high avidity T-cell receptor towards NY-ESO-1 have potent anti-tumor activity.Int J Cancer. Bd. 125. H. 3. 2009 S. 649-55
Viscoli, C; Herbrecht, R; Akan, H et al.
An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients.J Antimicrob Chemother. Bd. 64. H. 6. 2009 S. 1274-81
Joetham, A; Takeda, K; Okamoto, M et al.
Antigen specificity is not required for modulation of lung allergic responses by naturally occurring regulatory T cells.J Immunol. Bd. 183. H. 3. 2009 S. 1821-7
Michallet, M; Dreger, P; Sutton, L et al.
Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and WatchBLOOD. Bd. 114. H. 22. 2009 S. 361-361
Harbeck, N; Schmidt, M; Harter, P et al.
BIBW 2992, a Novel Irreversible EGFR/HER1 and HER2 Tyrosine Kinase Inhibitor for the Treatment of Patients with HER2-Negative Metastatic Breast Cancer after Failure of No More Than Two Prior ChemotherapiesCANCER RESEARCH. Bd. 69. H. 24. 2009 S. 785S-786S
Kolbe, K; Karstens, A; Krämer, I
Busulfan systemic exposure after oral administration of extemporeanously prepared high-dose busulfan capsulesJ Oncol Pharm Pract. Bd. 16. H. 3. 2009 S. 151-9
Sebastian, M; Kuemmel, A; Schmidt, M et al.
Catumaxomab: A bispecific trifunctional antibody.Drugs Today (Barc). Bd. 45. H. 8. 2009 S. 589-597
Wagner, EM; Lay, A; Schmitt, T et al.
CD8 DEPLETED DLI RECONSTITUTE FULL DONOR T-CELL CHIMERISM AND REPLENISH THE CD52-POSITIVE CD4 T CELL POOL AFTER ALEMTUZUMAB-BASED T-CELL DEPLETED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATIONHAEMATOLOGICA-THE HEMATOLOGY JOURNAL. Bd. 94. 2009 S. 56-56
Meyer, RG; Wagner, EM; Lay, AF et al.
CD8-depleted DLI convert mixed to full donor T-cell chimerism and replenishes the CD52-positive T-cell pool after alemtuzumab-based T-cell depleted allo-transplantationBONE MARROW TRANSPLANTATION. Bd. 43. 2009 S. S74-S74
Khan, S; Weterings, JJ; Britten, CM et al.
Chirality of TLR-2 ligand Pam(3)CysSK(4) in fully synthetic peptide conjugates critically influences the induction of specific CD8(+) T-cellsMOLECULAR IMMUNOLOGY. Bd. 46. H. 6. 2009 S. 1084-1091